How to buy Singular Genomics Systems stock (Singular Genomics Systems)

Singular Genomics Systems is a medical instruments & supplies business based in the US. Singular Genomics Systems shares (OMIC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $19.60 – a decrease of 1.31% over the previous week. Singular Genomics Systems employs 255 staff and has a trailing 12-month revenue of around $2.7 million.

Our top picks for where to buy Singular Genomics Systems stock

Buy Singular Genomics Systems stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Singular Genomics Systems stock price (NASDAQ: OMIC)

Use our graph to track the performance of OMIC stocks over time.

Singular Genomics Systems shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$19.60
52-week range	$5.34 - $23.41
50-day moving average more info button	$18.26
200-day moving average more info button	$12.93
Wall St. target price	$12.45
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-34.68

Is it a good time to buy Singular Genomics Systems stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Singular Genomics Systems price performance over time

Historical closes compared with the close of $19.71 from 2024-12-17

1 week (2024-12-12)	-0.76%
1 month (2024-11-19)	-8.41%
3 months (2024-09-19)	21.52%
6 months (2024-06-18)	5,872.73%

1 year (2023-12-19)	4,166.23%
2 years (2022-12-19)	-66.13%
3 years (2021-12-17)	326.1
5 years (2019-12-15)	N/A

Singular Genomics Systems financials

Revenue TTM	$2.7 million
Gross profit TTM	$-24,000
Return on assets TTM	-24.27%
Return on equity TTM	-51.61%
Profit margin	0%
Book value	$72.74
Market Capitalization more info button	$50.6 million

TTM: trailing 12 months

Singular Genomics Systems share dividends

We're not expecting Singular Genomics Systems to pay a dividend over the next 12 months.

You may also wish to consider:

Have Singular Genomics Systems's shares ever split?

Singular Genomics Systems's shares were split on a 1:30 basis on 25 June 2024 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Singular Genomics Systems shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Singular Genomics Systems shares which in turn could have impacted Singular Genomics Systems's share price.

Singular Genomics Systems share price volatility

Over the last 12 months, Singular Genomics Systems's shares have ranged in value from as little as $5.34 up to $23.41. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Singular Genomics Systems's is 1.514. This would suggest that Singular Genomics Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Singular Genomics Systems's beta into context you can compare it against those of similar companies.

• Illumina (ILMN.US): 1.131
• Crispr Therapeutics (CRSP.US): 1.662
• Bionano Genomics (BNGO.US): 2.376

Singular Genomics Systems overview

Singular Genomics Systems, Inc. , a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California. .

Frequently asked questions

What percentage of Singular Genomics Systems is owned by insiders or institutions?
Currently 13.901% of Singular Genomics Systems shares are held by insiders and 60.224% by institutions. How many people work for Singular Genomics Systems?
Latest data suggests 255 work at Singular Genomics Systems. When does the fiscal year end for Singular Genomics Systems?
Singular Genomics Systems's fiscal year ends in December. Where is Singular Genomics Systems based?
Singular Genomics Systems's address is: 3010 Science Park Road, San Diego, CA, United States, 92121 What is Singular Genomics Systems's ISIN number?
Singular Genomics Systems's international securities identification number is: US82933R1005